PharmaShots | Incisive News in 3 Shots

Subscribe Now

ALK

The US FDA Clears ALK’s Series of AccuTest Devices for Allergy Testing and Diagnosis

The US FDA Clears ALK’s Series of AccuTest Devices for Allergy Testing and Diagnosis

October 8, 2024

Takeda's Alunbrig (brigatinib) Receives EC's Approval as a 1L Treatment for ALK+ Advanced Non-Small Cell Lung Cancer

Takeda's Alunbrig (brigatinib) Receives EC's Approval as a 1L Treatment for ALK+ Advanced Non-Small Cell Lung Cancer

April 7, 2020

Genentech's Tecentriq Receives FDA Approval a Combination Therapy- for mNon-Sq NSCLC with No EGFR or ALK Genomic Tumor Aberrations

Genentech's Tecentriq Receives FDA Approval a Combination Therapy- for mNon-Sq NSCLC with No EGFR or ALK Genomic Tumor Aberrations

December 7, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us